Postoperative complications in patients with oculopharyngeal muscular dystrophy: A retrospective study

Canadian Journal of Anesthesia

Volumn 54, Issue 5, 2007, Pages 361-365

  Pellerin, Hélène G ^a,b   Nicole, Pierre C ^a   Trépanier, Claude A ^a   Lessard, Martin R ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; AMBULATORY SURGERY; ARTICLE; ASPIRATION PNEUMONIA; CONTROLLED STUDY; COUGHING; CRICOPHARYNGEUS MUSCLE; EXTRAOCULAR MUSCLE; FEMALE; GENERAL ANESTHESIA; HUMAN; INCIDENCE; LENGTH OF STAY; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUSCLE RESECTION; MYOTOMY; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PNEUMONIA; POSTANESTHESIA CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 34250175866     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03022658     Document Type: Article

References (15)

1. Taylor EW. Progressive vagus-glossopharyngeal paralysis with ptosis: a contribution to the group of family diseases. J Nerv Ment Dis 1915; 42: 129-39.
2. Amyot R. Hereditary, familial and acquired ptosis of late-onset. Can Med Assoc J 1948; 59: 434-8.
3. Victor M, Hayes R, Adams RD. Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the eyelids. N Engl J Med 1962; 267: 1267-72.
4. Bouchard JP. André Barbcau and the oculopharyngeal muscular dystrophy in French Canada and North America. Neuromuscul Disord 1997; 7(Suppl. 1): S5-11.
5. Codere F, Brais B, Rouleau G, Lafontaine E. Oculopharyngeal muscular dystrophy: what's new? Orbit 2001; 20: 259-66.
6. Blumen SC, Nisipeanu P, Sadeh M, et al. Epidemiology and inheritance of oculopharyngeal muscular dystrophy in Israel. Neuromuscul Disord 1997; 7(Suppl 1): S38-40.
7. Becher MW, Morrison L, Davis LE, et al. Oculopharyngeal muscular dystrophy in Hispanic New Mexicans. JAMA 2001; 286: 2437-40.
8. Duranceau AC, Beauchamp G, Jamieson GG, Barbeau A. Oropharyngeal dysphagia and oculopharyngeal muscular dystrophy. Surg Clin North Am 1983; 63: 825-32.
9. Fradet G, Pouliot D, Robichaud R, St-Pierre S, Bouchard JP. Upper esophageal sphincter myotomy in oculopharyngeal muscular dystrophy: long-term clinical results. Neurornuscul Discord 1997; 7(Suppl 1): S90-5.
10. Rodrigue D, Molgat YM. Surgical correction of blepharoptosis in oculopharyngeal muscular dystrophy. Neuromuscul Discord 1997; 7(Suppl 1): S82-4.
11. Landrum AL, Eggers GW. Oculopharyngeal dystrophy: an approach to anesthetic management. Anesth Analg 1992; 75: 1043-5.
12. Chun R, Ananthanarayan C. Safe use of mivacurium in oculopharyngeal muscular dystrophy. Can J Anaesth 1998; 45: 1134.
13. Christopher K, Horkan C, Patterson RB, Yodice PC. Oculopharyngeal muscular dystrophy complicating airway management. Chest 2001; 120: 2101-3.
14. Caron MJ, Girard F, Girard DC, et al. Cisatracurium pharmacodynamics in patients with oculopharyngeal muscular dystrophy. Anesth Analg 2005; 100: 393-7.
15. Plaud B, Duranceau A, Donati F. Dystrophie oculopharyngée (DOP) et blocage neuromusculaire avec le rocuronium. Ann Fr Anesth Réanim 2003; 22: S195 (abstract).